• unresectable
  • The authors retrospectively analyzed data from 442 patients with unresectable HCC who underwent their first session of chemoembolization without other procedure-related complications except postembolization syndrome between January 2005 and December 2006. (nih.gov)
  • Prognosis
  • Multicenter studies investigating the long-term outcomes of currently available therapeutic options in the thalassemia realm, in addition to novel HCC therapeutic targets, are needed to further improve the prognosis of these patients. (mdpi.com)
  • Agents
  • Evaluation of the potential of dipole field navigation for the targeted delivery of therapeutic agents in a human vascular network. (polymtl.ca)